CL2016000164A1 - Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv. - Google Patents

Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv.

Info

Publication number
CL2016000164A1
CL2016000164A1 CL2016000164A CL2016000164A CL2016000164A1 CL 2016000164 A1 CL2016000164 A1 CL 2016000164A1 CL 2016000164 A CL2016000164 A CL 2016000164A CL 2016000164 A CL2016000164 A CL 2016000164A CL 2016000164 A1 CL2016000164 A1 CL 2016000164A1
Authority
CL
Chile
Prior art keywords
adv
piii
hybridomas
secreted
antigen
Prior art date
Application number
CL2016000164A
Other languages
English (en)
Inventor
Ramírez Susan Marcela Bueno
Parra Alexis Mikes Kalergis
Alarcón Jorge Eugenio Mora
Original Assignee
Pontificia Universidad Católica De Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pontificia Universidad Católica De Chile filed Critical Pontificia Universidad Católica De Chile
Priority to CL2016000164A priority Critical patent/CL2016000164A1/es
Publication of CL2016000164A1 publication Critical patent/CL2016000164A1/es
Priority to PCT/IB2017/050312 priority patent/WO2017125892A2/es
Priority to MX2018008809A priority patent/MX2018008809A/es
Priority to EP20166433.1A priority patent/EP3756685A1/en
Priority to ES17741167T priority patent/ES2898068T3/es
Priority to US16/070,730 priority patent/US10766948B2/en
Priority to CN201780007470.2A priority patent/CN108697796B/zh
Priority to BR112018014538-6A priority patent/BR112018014538A2/pt
Priority to UY0001037082A priority patent/UY37082A/es
Priority to ARP170100158A priority patent/AR107440A1/es
Priority to EP17741167.5A priority patent/EP3406262B1/en
Priority to PT177411675T priority patent/PT3406262T/pt
Priority to CA3011569A priority patent/CA3011569A1/en
Priority to PE2018001294A priority patent/PE20181498A1/es
Priority to ZA2018/04705A priority patent/ZA201804705B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CL2016000164A 2016-01-21 2016-01-21 Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv. CL2016000164A1 (es)

Priority Applications (15)

Application Number Priority Date Filing Date Title
CL2016000164A CL2016000164A1 (es) 2016-01-21 2016-01-21 Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv.
PE2018001294A PE20181498A1 (es) 2016-01-21 2017-01-20 Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv
CN201780007470.2A CN108697796B (zh) 2016-01-21 2017-01-20 对于ADV感染的检测和诊断有用的由细胞杂交瘤产生和分泌的对人腺病毒（ADV）的pIII抗原具有特异性的单克隆抗体
UY0001037082A UY37082A (es) 2016-01-21 2017-01-20 Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv
EP20166433.1A EP3756685A1 (en) 2016-01-21 2017-01-20 Monoclonal antibodies specific for the piii antigen of human adenovirus (adv), produced and secreted by cell hybridomas, useful for detection and diagnosis of adv infection
ES17741167T ES2898068T3 (es) 2016-01-21 2017-01-20 Anticuerpos monoclonales específicos para el antígeno pIII de Adenovirus humano (ADV), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por ADV
US16/070,730 US10766948B2 (en) 2016-01-21 2017-01-20 Monoclonal antibodies specific for the pIII antigen of human Adenovirus (ADV), produced and secreted by cell hybridomas, useful for detection and diagnosis of ADV infection
PCT/IB2017/050312 WO2017125892A2 (es) 2016-01-21 2017-01-20 Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv
BR112018014538-6A BR112018014538A2 (pt) 2016-01-21 2017-01-20 anticorpos monoclonais específicos para o antígeno piii de adenovírus humano (adv), produzidos e secretados por hibridomas celulares, úteis para detecção e diagnóstico de infecção por adv
MX2018008809A MX2018008809A (es) 2016-01-21 2017-01-20 Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv.
ARP170100158A AR107440A1 (es) 2016-01-21 2017-01-20 ANTICUERPOS MONOCLONALES ESPECÍFICOS PARA EL ANTÍGENO pIII DE ADENOVIRUS HUMANO (ADV), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, ÚTILES PARA LA DETECCIÓN Y EL DIAGNÓSTICO DE LA INFECCIÓN CAUSADA POR ADV
EP17741167.5A EP3406262B1 (en) 2016-01-21 2017-01-20 Monoclonal antibodies specific for the piii antigen of human adenovirus (adv), produced and secreted by cell hybridomas, useful for detection and diagnosis of adv infection
PT177411675T PT3406262T (pt) 2016-01-21 2017-01-20 Anticorpos monoclonais específicos para o antigénio piii de adenovírus humano (adv), produzido e secretado por hibridomas celulares, úteis para deteção e diagnóstico de infeção por adv
CA3011569A CA3011569A1 (en) 2016-01-21 2017-01-20 Monoclonal antibodies specific for the piii antigen of human adenovirus (adv), produced and secreted by cell hybridomas, useful for detection and diagnosis of adv infection
ZA2018/04705A ZA201804705B (en) 2016-01-21 2018-07-13 Monoclonal antibodies specific for the piii antigen of human adenovirus (adv), produced and secreted by cell hybridomas, useful for detection and diagnosis of adv infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2016000164A CL2016000164A1 (es) 2016-01-21 2016-01-21 Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv.

Publications (1)

Publication Number Publication Date
CL2016000164A1 true CL2016000164A1 (es) 2016-07-29

Family

ID=56610130

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016000164A CL2016000164A1 (es) 2016-01-21 2016-01-21 Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv.

Country Status (14)

Country Link
US (1) US10766948B2 (es)
EP (2) EP3756685A1 (es)
CN (1) CN108697796B (es)
AR (1) AR107440A1 (es)
BR (1) BR112018014538A2 (es)
CA (1) CA3011569A1 (es)
CL (1) CL2016000164A1 (es)
ES (1) ES2898068T3 (es)
MX (1) MX2018008809A (es)
PE (1) PE20181498A1 (es)
PT (1) PT3406262T (es)
UY (1) UY37082A (es)
WO (1) WO2017125892A2 (es)
ZA (1) ZA201804705B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2018003869A1 (es) * 2018-12-28 2021-01-15 Univ Pontificia Catolica Chile Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv
CN113354727B (zh) * 2021-08-10 2021-11-02 北京溯本源和生物科技有限公司 一组同时检测b/c/e组腺病毒的单克隆抗体和试纸条
WO2024255566A1 (zh) * 2023-06-14 2024-12-19 珠海重链生物科技有限公司 抗人腺病毒抗体及其制备方法和应用
CN116789807B (zh) * 2023-06-14 2024-01-16 珠海重链生物科技有限公司 抗腺病毒单克隆抗体及其应用
CN117586385B (zh) * 2023-11-23 2024-05-17 广州医科大学附属第一医院（广州呼吸中心） 抗人4型腺病毒中和抗体及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487829A (en) 1982-03-23 1984-12-11 Massachusetts Institute Of Technology Production and use of monoclonal antibodies against adenoviruses
US6248514B1 (en) * 1996-07-09 2001-06-19 Canji, Inc. Methods for measuring viral infectivity
ES2286852T3 (es) 1997-08-04 2007-12-01 Advanced Life Science Institute, Inc. Metodos para detectar o analizar virus.
US6673614B2 (en) * 2000-06-27 2004-01-06 Cell Genesys, Inc. Rapid methods and kits for detection and semi-quantitation of anti-adenovirus antibody
IL153853A0 (en) * 2000-07-10 2003-07-31 Novartis Ag Bifunctional molecules and vectors complexed therewith for targeted gene delivery
EP1664099A2 (en) * 2003-09-09 2006-06-07 Niels Rudi Pedersen Adenoviral epitopes
CA2548942C (en) 2003-12-05 2013-10-15 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Anti-sars monoclonal antibodies
US8003108B2 (en) * 2005-05-03 2011-08-23 Amgen Inc. Sclerostin epitopes
EP2150276B1 (en) * 2007-05-03 2014-05-21 Agency For Science, Technology And Research Antibodies binding to an intracellular prl-1 or prl-3 polypeptide

Also Published As

Publication number Publication date
MX2018008809A (es) 2018-11-29
CN108697796A (zh) 2018-10-23
UY37082A (es) 2017-04-28
US20190048065A1 (en) 2019-02-14
EP3406262A4 (en) 2019-01-09
WO2017125892A3 (es) 2018-04-12
EP3406262B1 (en) 2021-07-28
EP3406262A2 (en) 2018-11-28
PE20181498A1 (es) 2018-09-18
EP3756685A1 (en) 2020-12-30
PT3406262T (pt) 2021-11-03
US10766948B2 (en) 2020-09-08
ES2898068T3 (es) 2022-03-03
ZA201804705B (en) 2019-09-25
CA3011569A1 (en) 2017-07-27
CN108697796B (zh) 2023-01-10
BR112018014538A2 (pt) 2018-12-26
WO2017125892A2 (es) 2017-07-27
AR107440A1 (es) 2018-05-02

Similar Documents

Publication Publication Date Title
EP3796927A4 (en) COMMON ANTIGENS
PT3802608T (pt) Anticorpos anti-cd3 e utilizações destes
EP3822289A4 (en) ANTI-SIRP-ALPHA ANTIBODIES
IL272349A (en) Anti-cd137 antibodies
PL3638698T3 (pl) Przeciwciała i fragmenty wiążące antygen anty-TMPRSS2
HUE053719T2 (hu) CTLA4 elleni monoklonális ellenanyag vagy annak antigénkötõ fragmentuma, gyógyásztati készítmény és alkalmazás
EP3589648A4 (en) MONOCLONAL ANTI-RSV ANTIBODY FORMULATION
IL289354A (en) Anti-cd154 antibodies and uses thereof
IL291545A (en) Anti-ctla4 antibodies, antibody fragments, their immunoconjugates and uses thereof
PT3548515T (pt) Anticorpos anti-pd-l1 radiomarcados para imagiologia imuno-pet
EP3459973A4 (en) Anti-human pd-l1 humanized monoclonal antibody and application thereof
EP3532489A4 (en) ANTI-TL1A NEUTRALIZING MONOCLONAL ANTIBODIES
MA43859A (fr) Anticorps monoclonaux humainisés immunostimulants dirigés contre l'interleukine -2 humaine, et leurs protéines de fusion
KR102587633B9 (ko) 수의학적 용도를 위한 인터류킨-31 단클론성 항체
DK3331910T3 (da) Monoklonale antistoffer mod humant b-cellemodningsantigen (bcma)
CL2015002152A1 (es) Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh
IL280757A (en) Monoclonal antibodies against human tim-3
IL281717A (en) Antibody formulation
CL2016000164A1 (es) Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv.
IL284807A (en) Antibodies specific to human nectin-2
PL3474904T3 (pl) Otrzymywanie przeciwciał monoklonalnych znakowanych 212pb
IL283875A (en) Anti-il-27 antibodies and uses thereof
EP3768724A4 (en) NEW ANTI-PD-1 ANTIBODIES
EP3888678A4 (en) Anti-pd-l1 antibody preparation
EP3690051A4 (en) MONOCLONAL ANTI-CKAP4 ANTIBODY